BMS Access Support is dedicated to helping patients access their prescribed BMS medications. We provide benefits reviews, prior authorization and appeals support, and reimbursement information to support patient access. Additionally, we offer financial support options and educational resources to support patients throughout their treatment journey.
EXPLORE PRODUCTS WE SUPPORT Read moreCoverage & Reimbursement Support
*BMS Access Support Data - Benefits review. Accessed August 2022.
Financial Support Options
Educational Resources
Enroll, track, and manage your patient cases in real time for select BMS medications.†
†Selected medications include AUGTYRO™ (repotrectinib), EMPLICITI® (elotuzumab), OPDIVO® (nivolumab), OPDUALAG™ (nivolumab and relatlimab-rmbw), SPRYCEL® (dasatinib), and YERVOY® (ipilimumab).
Schedule a call with a Patient Access Specialist to learn more about getting a patient started.
Learn about assistance programs for eligible patients based on insurance type.
VIEW OPTIONS
Find product-specific billing codes, reimbursement guides, distribution information, and coverage support offerings.
START HERE
Find standard forms and documents, office support tools, helpful guides, and videos.
EXPLORE NOW
U.S. Full Prescribing Information for ABRAXANE, including Boxed WARNING
U.S. Full Prescribing Information for IDHIFA, including Boxed WARNING
U.S. Full Prescribing Information for INREBIC, including Boxed WARNING
U.S. Full Prescribing Information for NULOJIX, including Boxed WARNINGS
U.S. Full Prescribing Information for POMALYST, including Boxed WARNINGS
U.S. Full Prescribing Information for REVLIMID, including Boxed WARNINGS
U.S. Full Prescribing Information for THALOMID, including Boxed WARNINGS